Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Th1 Cytokines, TNFα and IFNγ, Promote Corticosteroid Resistance in Developing Human Airway Smooth Muscle.

Britt RD Jr, Thompson MA, Sasse SK, Pabelick CM, Gerber AN, Prakash YS.

Am J Physiol Lung Cell Mol Physiol. 2018 Oct 18. doi: 10.1152/ajplung.00547.2017. [Epub ahead of print]

PMID:
30335498
2.

Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.

von Tresckow B, Kreissl S, Goergen H, Bröckelmann PJ, Pabst T, Fridrik M, Rummel M, Jung W, Thiemer J, Sasse S, Bürkle C, Baues C, Diehl V, Engert A, Borchmann P; German Hodgkin Study Group.

Lancet Haematol. 2018 Oct;5(10):e462-e473. doi: 10.1016/S2352-3026(18)30140-6.

PMID:
30290903
3.

Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD-1-treatment.

Sasse S, Reddemann K, Diepstra A, Oschlies I, Schnitter A, Borchmann S, Engert A, Borchmann P, Klapper W.

Haematologica. 2018 Aug 3. pii: haematol.2018.196279. doi: 10.3324/haematol.2018.196279. [Epub ahead of print] No abstract available.

4.

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

Sasse S, Goergen H, Plütschow A, Böll B, Eichenauer DA, Fuchs M, Behringer K, Zijlstra JM, Greil R, Markova J, Topp MS, Meissner J, Neubauer A, Baues C, Engert A, Borchmann P, von Tresckow B.

J Clin Oncol. 2018 Sep 1;36(25):2603-2611. doi: 10.1200/JCO.2018.78.7192. Epub 2018 Jul 10.

PMID:
29989855
5.

Long-Acting β2-Adrenoceptor Agonists Enhance Glucocorticoid Receptor (GR)-Mediated Transcription by Gene-Specific Mechanisms Rather Than Generic Effects via GR.

Rider CF, Altonsy MO, Mostafa MM, Shah SV, Sasse S, Manson ML, Yan D, Kärrman-Mårdh C, Miller-Larsson A, Gerber AN, Giembycz MA, Newton R.

Mol Pharmacol. 2018 Sep;94(3):1031-1046. doi: 10.1124/mol.118.112755. Epub 2018 Jun 29.

PMID:
29959223
6.

Microenvironmental support for cell delivery to the inner ear.

Schulze J, Sasse S, Prenzler N, Staecker H, Mellott AJ, Roemer A, Durisin M, Lenarz T, Warnecke A.

Hear Res. 2018 Oct;368:109-122. doi: 10.1016/j.heares.2018.06.015. Epub 2018 Jun 21.

PMID:
29945803
7.

The Nonlinear Development of Emotion Differentiation: Granular Emotional Experience Is Low in Adolescence.

Nook EC, Sasse SF, Lambert HK, McLaughlin KA, Somerville LH.

Psychol Sci. 2018 Aug;29(8):1346-1357. doi: 10.1177/0956797618773357. Epub 2018 Jun 7.

PMID:
29878880
8.

Dissecting "Peer Presence" and "Decisions" to Deepen Understanding of Peer Influence on Adolescent Risky Choice.

Somerville LH, Haddara N, Sasse SF, Skwara AC, Moran JM, Figner B.

Child Dev. 2018 Apr 27. doi: 10.1111/cdev.13081. [Epub ahead of print]

PMID:
29701282
9.

Balancing risk and benefit in early-stage classical Hodgkin lymphoma.

Bröckelmann PJ, Sasse S, Engert A.

Blood. 2018 Apr 12;131(15):1666-1678. doi: 10.1182/blood-2017-10-772665. Epub 2018 Mar 2. Review.

PMID:
29500174
10.

Increasing verbal knowledge mediates development of multidimensional emotion representations.

Nook EC, Sasse SF, Lambert HK, McLaughlin KA, Somerville LH.

Nat Hum Behav. 2017;1:881-889. doi: 10.1038/s41562-017-0238-7. Epub 2017 Nov 27.

11.

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA.

J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.

PMID:
29394125
12.

Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells.

Lemcke H, Gaebel R, Skorska A, Voronina N, Lux CA, Petters J, Sasse S, Zarniko N, Steinhoff G, David R.

Sci Rep. 2017 Aug 29;7(1):9755. doi: 10.1038/s41598-017-10122-6.

13.

A systematic review of national policies for the management of persons exposed to tuberculosis.

Rodriguez CA, Sasse S, Yuengling KA, Azzawi S, Becerra MC, Yuen CM.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):935-940. doi: 10.5588/ijtld.17.0061. Review.

PMID:
28786803
14.

Update in Natural Orifice Translumenal Endoscopic Surgery (NOTES).

Bernhardt J, Sasse S, Ludwig K, Meier PN.

Curr Opin Gastroenterol. 2017 Sep;33(5):346-351. doi: 10.1097/MOG.0000000000000385. Review.

PMID:
28742537
15.

Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.

Hude I, Sasse S, Bröckelmann PJ, von Tresckow B, Momotow J, Engert A, Borchmann S.

Br J Haematol. 2018 Jun;181(6):837-840. doi: 10.1111/bjh.14705. Epub 2017 Apr 25. No abstract available.

PMID:
28439879
16.

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.

Sasse S, Bröckelmann PJ, Goergen H, Plütschow A, Müller H, Kreissl S, Buerkle C, Borchmann S, Fuchs M, Borchmann P, Diehl V, Engert A.

J Clin Oncol. 2017 Jun 20;35(18):1999-2007. doi: 10.1200/JCO.2016.70.9410. Epub 2017 Apr 18.

PMID:
28418763
17.

Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy.

Sasse SK, Kadiyala V, Danhorn T, Panettieri RA Jr, Phang TL, Gerber AN.

Am J Respir Cell Mol Biol. 2017 Aug;57(2):226-237. doi: 10.1165/rcmb.2016-0357OC.

18.

Biological therapies in otology.

Roemer A, Staecker H, Sasse S, Lenarz T, Warnecke A.

HNO. 2017 Aug;65(Suppl 2):87-97. doi: 10.1007/s00106-016-0306-8.

PMID:
28353079
19.

Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.

Helling BA, Gerber AN, Kadiyala V, Sasse SK, Pedersen BS, Sparks L, Nakano Y, Okamoto T, Evans CM, Yang IV, Schwartz DA.

Am J Respir Cell Mol Biol. 2017 Jul;57(1):91-99. doi: 10.1165/rcmb.2017-0046OC.

20.

[Biological therapies in otology. German version].

Roemer A, Staecker H, Sasse S, Lenarz T, Warnecke A.

HNO. 2017 Jul;65(7):571-585. doi: 10.1007/s00106-016-0304-x. German.

PMID:
28204850
21.

Repulsive Epithelial Cues Direct Glial Migration along the Nerve.

Sasse S, Klämbt C.

Dev Cell. 2016 Dec 19;39(6):696-707. doi: 10.1016/j.devcel.2016.11.016.

22.

Charting the expansion of strategic exploratory behavior during adolescence.

Somerville LH, Sasse SF, Garrad MC, Drysdale AT, Abi Akar N, Insel C, Wilson RC.

J Exp Psychol Gen. 2017 Feb;146(2):155-164. doi: 10.1037/xge0000250. Epub 2016 Dec 15.

PMID:
27977227
23.

The emerging role of immune checkpoint inhibition in malignant lymphoma.

Hude I, Sasse S, Engert A, Bröckelmann PJ.

Haematologica. 2017 Jan;102(1):30-42. doi: 10.3324/haematol.2016.150656. Epub 2016 Nov 24. Review.

24.

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).

Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J, Illerhaus G.

Leukemia. 2017 Apr;31(4):846-852. doi: 10.1038/leu.2016.334. Epub 2016 Nov 15.

25.

Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.

Sasse SK, Altonsy MO, Kadiyala V, Cao G, Panettieri RA Jr, Gerber AN.

Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L421-32. doi: 10.1152/ajplung.00179.2016. Epub 2016 Jul 1.

26.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program.

Zinzani PL, Sasse S, Radford J, Gautam A, Bonthapally V.

Crit Rev Oncol Hematol. 2016 Aug;104:65-70. doi: 10.1016/j.critrevonc.2016.04.019. Epub 2016 May 21. Review.

27.

Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects.

Kadiyala V, Sasse SK, Altonsy MO, Berman R, Chu HW, Phang TL, Gerber AN.

J Biol Chem. 2016 Jun 10;291(24):12673-87. doi: 10.1074/jbc.M116.721217. Epub 2016 Apr 13.

28.

Cistrome Analysis of Glucocorticoid Receptor Activity in Bronchial Epithelial Cells Defines Novel Mechanisms of Steroid Efficacy.

Kadiyala V, Sasse SK, Altonsy MO, Phang TL, Gerber AN.

Ann Am Thorac Soc. 2016 Mar;13 Suppl 1:S103. doi: 10.1513/AnnalsATS.201508-534MG. No abstract available.

29.

Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group.

Sasse S, Alram M, Müller H, Smardová L, Metzner B, Doehner H, Fischer T, Niederwieser DW, Schmitz N, Schäfer-Eckart K, Raemaekers JM, Schmalz O, Tresckow BV, Engert A, Borchmann P.

Leuk Lymphoma. 2016 May;57(5):1067-73. doi: 10.3109/10428194.2015.1083561. Epub 2015 Dec 23.

PMID:
26693800
30.

Differentiation of Drosophila glial cells.

Sasse S, Neuert H, Klämbt C.

Wiley Interdiscip Rev Dev Biol. 2015 Nov-Dec;4(6):623-36. doi: 10.1002/wdev.198. Epub 2015 Jul 15. Review.

PMID:
26178654
31.

Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.

Haverkamp H, Böll B, Eichenauer DA, Sasse S, Fuchs M, Borchmann P, Diehl V, Engert A, von Tresckow B.

J Clin Oncol. 2015 Aug 1;33(22):2430-6. doi: 10.1200/JCO.2014.60.4264. Epub 2015 Jun 22.

PMID:
26101245
32.

Response Element Composition Governs Correlations between Binding Site Affinity and Transcription in Glucocorticoid Receptor Feed-forward Loops.

Sasse SK, Zuo Z, Kadiyala V, Zhang L, Pufall MA, Jain MK, Phang TL, Stormo GD, Gerber AN.

J Biol Chem. 2015 Aug 7;290(32):19756-69. doi: 10.1074/jbc.M115.668558. Epub 2015 Jun 18.

33.

A transcriptional network controlling glial development in the Drosophila visual system.

Bauke AC, Sasse S, Matzat T, Klämbt C.

Development. 2015 Jun 15;142(12):2184-93. doi: 10.1242/dev.119750. Epub 2015 May 26.

34.

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature.

Zinzani PL, Sasse S, Radford J, Shonukan O, Bonthapally V.

Crit Rev Oncol Hematol. 2015 Sep;95(3):359-69. doi: 10.1016/j.critrevonc.2015.03.011. Epub 2015 Apr 27. Review.

PMID:
25964164
35.

A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.

Rothe A, Sasse S, Topp MS, Eichenauer DA, Hummel H, Reiners KS, Dietlein M, Kuhnert G, Kessler J, Buerkle C, Ravic M, Knackmuss S, Marschner JP, Pogge von Strandmann E, Borchmann P, Engert A.

Blood. 2015 Jun 25;125(26):4024-31. doi: 10.1182/blood-2014-12-614636. Epub 2015 Apr 17.

36.

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.

Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann HW, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie.

Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22. Erratum in: Lancet. 2015 Apr 11;385(9976):1396.

PMID:
25539730
37.

Feed-forward transcriptional programming by nuclear receptors: regulatory principles and therapeutic implications.

Sasse SK, Gerber AN.

Pharmacol Ther. 2015 Jan;145:85-91. doi: 10.1016/j.pharmthera.2014.08.004. Epub 2014 Aug 25. Review.

38.
39.

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.

Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T, Klimm B, Diehl V, Sasse S, Rothe A, Fuchs M, Böll B, von Tresckow B, Borchmann P, Engert A.

Blood. 2014 Mar 13;123(11):1658-64. doi: 10.1182/blood-2013-07-512657. Epub 2014 Jan 29.

40.

Dividing cells regulate their lipid composition and localization.

Atilla-Gokcumen GE, Muro E, Relat-Goberna J, Sasse S, Bedigian A, Coughlin ML, Garcia-Manyes S, Eggert US.

Cell. 2014 Jan 30;156(3):428-39. doi: 10.1016/j.cell.2013.12.015. Epub 2014 Jan 23.

41.

Central gene expression changes associated with enhanced neuroendocrine and autonomic response habituation to repeated noise stress after voluntary wheel running in rats.

Sasse SK, Nyhuis TJ, Masini CV, Day HE, Campeau S.

Front Physiol. 2013 Nov 25;4:341. doi: 10.3389/fphys.2013.00341. eCollection 2013.

42.

Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.

Böll B, Goergen H, Arndt N, Meissner J, Krause SW, Schnell R, von Tresckow B, Eichenauer DA, Sasse S, Fuchs M, Behringer K, Klimm BC, Naumann R, Diehl V, Engert A, Borchmann P.

J Clin Oncol. 2013 Dec 10;31(35):4431-7. doi: 10.1200/JCO.2013.49.8246. Epub 2013 Nov 4.

PMID:
24190119
43.

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant.

von Tresckow B, Müller H, Eichenauer DA, Glossmann JP, Josting A, Böll B, Klimm B, Sasse S, Fuchs M, Borchmann P, Engert A.

Leuk Lymphoma. 2014 Aug;55(8):1922-4. doi: 10.3109/10428194.2013.854888. Epub 2014 Jan 28. No abstract available.

PMID:
24138304
44.

18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.

Kahraman D, Theurich S, Rothe A, Kuhnert G, Sasse S, Scheid C, Dietlein M, Drzezga A, von Bergwelt-Baildon M, Kobe C.

Leuk Lymphoma. 2014 Apr;55(4):811-6. doi: 10.3109/10428194.2013.819575. Epub 2013 Jul 29.

PMID:
23805904
45.

Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.

Wongso D, Fuchs M, Plütschow A, Klimm B, Sasse S, Hertenstein B, Maschmeyer G, Vieler T, Dührsen U, Lindemann W, Aulitzky W, Diehl V, Borchmann P, Engert A.

J Clin Oncol. 2013 Aug 1;31(22):2819-24. doi: 10.1200/JCO.2012.47.9774. Epub 2013 Jun 24.

PMID:
23796987
46.

The glucocorticoid receptor and KLF15 regulate gene expression dynamics and integrate signals through feed-forward circuitry.

Sasse SK, Mailloux CM, Barczak AJ, Wang Q, Altonsy MO, Jain MK, Haldar SM, Gerber AN.

Mol Cell Biol. 2013 Jun;33(11):2104-15. doi: 10.1128/MCB.01474-12. Epub 2013 Mar 18.

47.

Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma.

Sasse S, Rothe A, Goergen H, Eichenauer DA, Lohri A, Kreher S, Jäger U, Bangard C, Kuhnert G, Böll B, von Tresckow B, Engert A.

Leuk Lymphoma. 2013 Oct;54(10):2144-8. doi: 10.3109/10428194.2013.775434. Epub 2013 Mar 27.

PMID:
23402268
48.

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.

Rothe A, Sasse S, Goergen H, Eichenauer DA, Lohri A, Jäger U, Bangard C, Böll B, von Bergwelt Baildon M, Theurich S, Borchmann P, Engert A.

Blood. 2012 Aug 16;120(7):1470-2. doi: 10.1182/blood-2012-05-430918. Epub 2012 Jul 11. Erratum in: Blood. 2014 Aug 14;124(7):1201.

49.

Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.

Sasse S, Klimm B, Görgen H, Fuchs M, Heyden-Honerkamp A, Lohri A, Koch O, Wilhelm M, Trenn G, Finke J, Müller RP, Diehl V, Eich HT, Borchmann P, Engert A; German Hodgkin Study Group (GHSG).

Ann Oncol. 2012 Nov;23(11):2953-9. doi: 10.1093/annonc/mds110. Epub 2012 Jul 5.

PMID:
22767583
50.

Stable release of BDNF from the fibroblast cell line NIH3T3 grown on silicone elastomers enhances survival of spiral ganglion cells in vitro and in vivo.

Warnecke A, Sasse S, Wenzel GI, Hoffmann A, Gross G, Paasche G, Scheper V, Reich U, Esser KH, Lenarz T, Stöver T, Wissel K.

Hear Res. 2012 Jul;289(1-2):86-97. doi: 10.1016/j.heares.2012.04.007. Epub 2012 Apr 28.

PMID:
22564255

Supplemental Content

Support Center